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Abstract
Background: Sperm quality may degrade during transit through the male reproductive tract in some individuals. In
this setting surgically retrieved testicular sperm may outperform ejaculated samples for use with in vitro fertilization
(IVF) and intracytoplasmic sperm injection (IVF-ICSI). We sought to describe one center’s experience with the use of
fresh testicular sperm after prior failed IVF-ICSI with ejaculated samples.
Results: A retrospective review was conducted evaluating IVF-ICSI cycles performed at a tertiary IVF unit between
2009 and 2014. Couples who were managed with percutaneous testis biopsy to obtain sperm, despite availability of
ejaculated sperm, were included. Four couples who underwent a total of 6 percutaneous testis biopsy/IVF-ICSI
cycles were identified. Collectively, the couples had undergone 9 prior IVF-ICSI cycles using fresh ejaculated sperm
without successful pregnancy. From the six cycles that used fresh testicular sperm four live births resulted (1 twin
gestation, 3 singletons). Only 1 of the 4 couples remained childless.
Conclusions: For patients who have had prior failed IVF-ICSI attempts, this small case series demonstrates a
possible therapeutic benefit when freshly procured testicular sperm are used in lieu of ejaculated samples.
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Background
With the advent of in vitro fertilization (IVF) and
intracytoplasmic sperm injection (IVF-ICSI), many men
with severe male factor infertility can now be offered the
opportunity to parent their own genetic offspring. Un-
fortunately, a subset of patients will not succeed despite
these advanced treatments. Although the chance of a
live birth continues to rise with an increasing number of
IVF cycles, up to 19 % of couples will remain childless
following 8 attempts [1]. Given the financial, physical,
and psychological demands each IVF cycle requires [2],
a significant drop-out rate accrues with each successive
treatment [3].
For some couples with multiple failed IVF cycles,
sperm-related factors may play a principle role. Unfortu-
nately, robust indicators of sperm quality have yet to be
identified. Most centers routinely select for sperm based
upon visual cues such as motility and morphology. Fresh
ejaculated sperm, when available, are generally preferred
over surgically retrieved samples given the need for an
invasive procedure. These practice patterns are often
based upon the belief that immature testicular sperm
may be less likely to result in a successful pregnancy.
However, this tenet is increasingly being challenged as
IVF-ICSI outcomes correlate poorly with traditional
sperm quality parameters [4, 5]. Studies involving large
cohorts have now shown near equivalence with samples
retrieved from the epididymis or testis [6–8], and even
with sperm characterized by poor motility and morph-
ology [5]. In the extreme scenario of substantial necros-
permia, testicular sperm may even outperform viable
ejaculated samples [9].
Investigators have begun to focus on more sophisti-
cated rubrics of sperm quality in order to understand
and optimize IVF-ICSI outcomes. Reactive oxygen
species (ROS) and DNA damage have been two areas of
intense investigation. Preliminary research has also
shown that sperm quality, especially in terms of DNA
integrity, may decrease in some patients as the
spermatozoa transit through the male reproductive
tract [10–12]. As a result, some couples may benefit
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from testis-derived sperm even in the presence of vi-
able sperm in the ejaculate.
Although it is difficult to rule out an occult sperm-
related etiology when evaluating a couple with recurrent
IVF failure, an attempt with testicular sperm is an option
rarely offered when ejaculated sperm are available. The
following case series explores the premise that a subset
of couples may benefit from freshly procured testicular
sperm in an attempt to bypass male factors related to
post-testicular events.
Methods
IRB approval was obtained for this investigation. A
retrospective chart review was conducted to evaluate all
IVF-ICSI cycles at a tertiary referral center. Records
from January 2010 to January 2014 were examined. In-
clusion criteria consisted of couples who were managed
with percutaneous testis biopsy (PercBx) for any indica-
tion at our institution. A total of 19 consecutive cases
were identified. Men who had obstructive azoospermia
as the indication for PercBx were excluded from the
study population, which resulted in four unique couples
(Table 1) who underwent a total of six IVF-ICSI treat-
ment cycles using freshly retrieved testicular sperm
(Table 2). Cryopreservation was not included in our
treatment protocol to avoid diminished sperm yields
from the freeze-thaw cycle, and to avoid the theoretical
risk of reduced implantation rates [13].
All couples had undergone at least one unsuccessful
IVF-ICSI cycle using a fresh ejaculated sample (mean
2.25 cycles) prior to proceeding to IVF-ICSI with
PercBx. Female partners were evaluated by a reproduct-
ive endocrinologist and optimized for another IVF-ICSI
cycle. Each male partner underwent thorough urologic
evaluation and informed consent prior to proceeding
with percutaneous testis biopsy. Semen analyses were
interpreted according to the 2010 WHO guidelines. Nor-
mal testis volume was considered > 15 mL. All patients
underwent a basic endocrine work-up, including follicle
stimulating hormone (FSH, lab normal < 12 mIU/mL),
and morning total testosterone (normal > 270 ng/dL).
All sperm procurements were coordinated on the day
of oocyte retrieval. Male evaluations and testicular biop-
sies were performed by a single reproductive urologist
(CT). After initiating local anesthesia via a spermatic
cord block an 18-gauge hollow core biopsy needle was
used to percutaneously procure 4 to 10 cores of testicu-
lar parenchyma. An embryologist provided immediate
feedback to confirm the presence of adequate numbers
of sperm for the anticipated number of oocytes. Unilat-
eral biopsy was sufficient in each circumstance.
Results
Case 1
The couple presented with a history of 4 failed IVF-ICSI
cycles in the setting of known oligoasthenoteratospermia
(OAT). Further testing revealed an elevated sperm DNA
fragmentation index (DFI). The female partner was
31 years old with an unremarkable gynecologic evaluation.
Her partner was a healthy 34-year-old nonsmoker with
no prior conceptions or conception attempts. On phys-
ical exam the patient was found to have symmetric 27 cc
testes. There was no palpable varicocele. His FSH was
1.2 mIU/mL and his morning testosterone was 420 ng/dL.
Four semen analyses were available and remarkable for
variable OAT, with concentrations 0.1 – 27 million/cc,
progressive motility 0 – 25 %, and Kruger morph-
ology 0 – 1 % normal forms. Total motile counts
ranged from 0.3 to 13 million. His karyotype was
normal.
The couple’s four prior IVF-ICSI attempts utilized
ejaculated sperm. Each cycle resulted in the retrieval of
8 to 14 mature oocytes. The first cycle resulted in an
early spontaneous abortion. The second attempt yielded
no fertilized oocytes. Fertilization rates of the third and
fourth cycles were 44 % and 64 % with 1 and 2 embryos
transferred, respectively. Neither cycle resulted in preg-
nancy. Given the couple’s history of 4 failed IVF-ICSI
cycles a sperm chromatin structure assay (SCSA) was or-
dered, noting an elevated DFI of 44.2 %.
In light of four unsuccessful IVF-ICSI cycles and indi-
cators of poor sperm quality, including elevated DFI, the




Age Infertility diagnoses Age Infertility diagnoses
Case 1 4 34 OATa 31 None
Elevated DFIb
Case 2 1 49 OAT 37 Advanced Maternal Age
Corrected Uterine Factor
Case 3 3 32 Kartagener’s Syndrome 32 Corrected Uterine Factor
Case 4 1 46 OAT 38 Advanced Maternal Age
Elevated DFI Decreased Ovarian Reserve
aOligoasthenoteratospermia, bDNA fragmentation index
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couple was counseled to consider an attempt using a
fresh testicular sperm extraction at the time of oocyte
retrieval. The couple chose to pursue this option; eleven
mature oocytes were retrieved, all of which were injected
with fresh testicular sperm. Five oocytes fertilized with
two day three embryos (8 cell, 7 cell) transferred. A
resulting healthy singleton pregnancy was delivered.
Case 2
The couple presented with one failed IVF-ICSI cycle
marked by poor embryo development in the context of
cryptozoospermia following vasectomy reversal. The fe-
male partner was 37 years old with no prior history of
conception. Her evaluation was notable only for a small
endometrial polyp that was resected. Follow-up transva-
ginal ultrasound confirmed a normal uterine cavity.
Her partner was a 49-year-old nonsmoker with one
prior spontaneous conception with another partner prior
to his vasectomy 12 years earlier. He had undergone a
vasectomy reversal 4 years after initial vasectomy. On
exam his testes were 27 cc in volume, and there were no
palpable varicoceles. Although he initially had return of
motile sperm to the ejaculate (1 – 8 million total motile
sperm per sample), his semen analyses demonstrated a
progressive deterioration of motile counts prior to refer-
ral to our center. Five preoperative semen analyses were
available. At the time of treatment samples required cen-
trifugation with fewer than 20 immotile sperm obtained
per pelleted sample. His hormonal profile was otherwise
reassuring with an FSH of 2.0 mIU/mL and a morning
serum testosterone of 423 ng/dL.
The couple’s initial IVF-ICSI attempt utilized rare im-
motile sperm from an ejaculated sample identified only
after several hours of searching by two embryologists. A
total of five mature oocytes were retrieved and two fer-
tilized. Both embryos arrested at the 2-cell stage prior to
a transfer attempt.
Due to the degree of cryptozoospermia and poor em-
bryo development evident with the first cycle attempt,
the couple opted to pursue a second cycle using freshly-
retrieved testicular sperm. Twitching sperm were ob-
tained and five of 11 mature oocytes fertilized normally.
Two high quality embryos (8-cell, 6-cell) were trans-
ferred on day three. A singleton pregnancy resulted with
successful term delivery of a healthy male infant.
Case 3
The third couple was characterized by multiple failed
IVF-ICSI cycles using fresh ejaculated immotile sperm
in the setting of known Kartagener’s Syndrome in the
male. The female partner was 32 years old with no prior
conceptions or attempts. She had a history of symptom-
atic mural fibroids for which she underwent laparoscopic
myomectomy without complication. Subsequent office
hysteroscopy confirmed a normal uterine cavity. Her
testing and evaluation were otherwise unremarkable.
Her partner was a 32-year-old nonsmoker who was di-
agnosed with Kartagener’s Syndrome at the age of three.
On exam his testes were symmetric and 32 cc’s in vol-
ume, and there were no clinical varicoceles. His endo-
crine workup revealed an FSH of 4.9 mIU/mL and a
morning serum testosterone of 437 ng/dL. Semen ana-
lyses, as expected, demonstrated a complete absence of
motility. Over the course of his evaluation, six semen
analyses were performed. Concentrations ranged from 8
to 19 million/cc (total count 16 to 38 million) with 0 to
2 % normal forms by strict criteria.
Following the female partner’s myomectomy and
post-operative recovery, the couple had undergone
three IVF-ICSI attempts using fresh ejaculated sperm.
Each cycle resulted in the retrieval of 4 to 12 mature
oocytes, with resulting fertilization rates of 0 to 42 %.
A single blastocyst was transferred during the first
cycle without success. The second and third cycles
utilized sperm selected based upon the hypo-osmotic
swelling assessment in an effort to optimize out-
comes. Viability testing was also judged with the
mechanical touch technique, which uses a combin-
ation of morphology and tail flexibility for assessment
[14]. Two day three embryos were transferred with
the third cycle resulting in a biochemical pregnancy
that did not progress.
Following the three failed cycles, the couple elected
for another attempt using fresh testicular sperm. This











Case 1 13 (11) 5 (45) 3 8 cell, 7 cell Singleton Delivered
Case 2 16 (11) 5 (45) 2 8 cell, 6 cell Singleton Delivered
Case 3 14 (13) 9 (69) 7 10 cell, 8 cell Singleton Delivered
17 (16) 7 (43) 2 10 cell, 8 cell Twins Delivered
Case 4 5 (3) 0 (0) NA NA NA
3 (3) 2 (67) 2 7 cell, 6 cell Terminated Ectopic
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cycle resulted in the retrieval of 13 mature oocytes, nine
of which fertilized. Two high quality embryos (10-cell,
8-cell) were transferred on day three. The couple suc-
cessfully delivered a singleton pregnancy at term. A
single resulting blastocyst was also frozen.
The couple desired further family building and pur-
sued transfer of their remaining frozen blastocyst. Un-
fortunately no pregnancy resulted, and the couple
proceeded to another IVF-ICSI attempt using freshly
procured testicular sperm. With this cycle, seven of 16
mature oocytes fertilized normally and two day three
embryos were transferred (8-cell, 10-cell). A resulting
twin pregnancy was successfully delivered.
Case 4
The final couple presented with both decreased ovarian
reserve and OAT in combination with an elevated sperm
DFI. The woman was 38 years old when she initiated
treatment at our center. A previous fertility evaluation
had demonstrated a day three FSH of 10.8 (normal < 9)
and an antral follicle count of 9 (ideally > 14). The re-
mainder of her workup was unremarkable.
Her partner was a 46-year-old nonsmoker who had a
history of vasectomy 15 years prior, which was then re-
versed after a 14 year obstructive interval. He initially
had return of motile sperm to the ejaculate with pro-
gression over time to OAT. His sperm concentrations
dropped from a high of 9 to 0.3 million/cc, presumably
due to partial anastomotic stenosis. At the time of our
evaluation, by now his fifth semen analysis, sperm con-
centration had further declined to 0.1 million/cc with
25 % progressive motility and 3 % normal morphology
(<1 million total motile sperm). The patient otherwise
had a reassuring hormonal profile, with an FSH of 3.8
mIU/mL and a morning serum testosterone of 474 ng/dL.
His exam demonstrated 30 cc testes bilaterally with a
small left varicocele.
The couple’s initial IVF-ICSI attempt using fresh
ejaculated sperm resulted in the retrieval of 6 mature
oocytes, only one of which fertilized. The resulting 5-cell
embryo was transferred on day three and ended in bio-
chemical pregnancy without progression. An SCSA was
subsequently obtained demonstrating an elevated DFI of
42.8 %.
Given the elevated DFI, poor fertilization rate, and un-
successful outcome of their first cycle, the couple chose
to proceed with another IVF-ICSI cycle using fresh tes-
ticular sperm. Two subsequent testicular sperm extrac-
tion cycles were conducted: the first IVF cycle resulted
in the retrieval of three mature oocytes, none of which
fertilized following injection with motile sperm. With
the second cycle a total of three mature oocytes were re-
trieved, two of which fertilized. Both embryos were
transferred on day three (6-cell, 7-cell). An ectopic
pregnancy resulted and was managed medically. After-
ward, the couple elected to stop further IVF attempts.
Discussion
The sperm-related factors that result in limited
fertilization, poor embryo development, impaired im-
plantation, and early spontaneous abortion are poorly
understood. Historically, sperm motility and morphology
have been the primary surrogates for sperm quality; early
studies substantiated this concept in terms of poorer
male factor-related outcomes using IVF with conventional
insemination [15–17]. However, the predictive values of
morphology and motility have been questioned when the
standard insemination process is bypassed [18, 19]. In an
effort to better characterize sperm quality in the era of
IVF-ICSI, investigations into more sophisticated measures
of sperm quality such as oxidative damage and impaired
DNA integrity have been pursued.
A relationship between oxidative stress and subfertility
has now been established. Elevated seminal ROS are
negatively correlated with sperm concentration, motility,
and morphology [20, 21]. Additionally, elevated ROS are
found in men who have undergone vasectomy reversal
[22]. Cases 2 and 4 are characterized by OAT in men
who were previously treated with vasovasostomy. It is
unclear if elevated ROS played a dominant role in these
cases, although their presentations can be considered
consistent with oxidative stress.
A direct link between sperm oxidative damage and
embryo demise has been demonstrated in animal models
[23]. Additionally, elevated seminal ROS are correlated
with poor embryo development in humans [24]. Rela-
tively little is known regarding the accumulation of oxi-
dative damage as sperm progress through the male
reproductive tract. Ollero et al. postulated that the pres-
ence of immature spermatozoa, a known source for en-
dogenous ROS [25], may result in damage to mature
sperm during transit through the epididymis [26]. The
local environment within the epididymis may be further
stressed as a vasovasostomy site begins to stenose. As
pressure builds within the testicular side of the anasto-
mosis, progressive epididymal dysfunction may ensue,
particularly in a system that has suffered iatrogenic ob-
struction in the past [27]. The use of testicular sperm
may bypass this potentially toxic local environment, and
may translate into improved IVF-ICSI outcomes in pa-
tients with similar profiles as Cases 2 and 4.
A known result of oxidative stress is DNA damage,
which is a prominent feature of Cases 1 and 4. For both
patients an SCSA revealed a DFI above 40 %. In one of
the largest series by Bungum et al., a DFI greater than
30 % was found to translate into an odds ratio of 0.1
(CI 0.02 – 0.42) for clinical pregnancy rates following
intrauterine insemination [28]. Their data found no
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statistical difference for their conventional IVF and
IVF-ICSI cohorts, which was initially attributed to selec-
tion bias regarding oocyte quality. A subsequent meta-
analysis corroborated these findings regarding IVF-ICSI
and an elevated DFI, although a trend toward a higher
miscarriage rate was noted [29]. Despite the fact that IVF-
ICSI outcomes remain favorable even in states of marked
DNA damage [30], conceivably due to the DNA repair
capacity of high quality oocytes [31], the possibility re-
mains that a subset of patients may be particularly affected
by an elevated DFI. Greco and colleagues examined a
small cohort of couples who were similar to Case 1:
patients who were characterized by an elevated DFI and
recurrent IVF-ICSI failure using ejaculated sperm [11].
They found that testis-derived samples had significantly
less DNA damage. Although fertilization rates and embryo
development were no different in the testis versus ejacu-
lated samples, the testicular sperm achieved eight clinical
pregnancies as opposed to one in the control group. They
postulated that significant DNA damage accrues during
transit though the epididymis, similar to the concept
raised by Ollero et al. [26].
Some investigators have attempted to treat impaired
DNA integrity with antioxidants in order to limit oxida-
tive stress. Abad et al. demonstrated a modest improve-
ment in semen parameters and DFI following 3 months
of oral antioxidant therapy in a group of infertile men
[32]. In the case of testicular derived sperm, a small case
series by Greco et al. found improved ICSI outcomes
when men with poor DNA integrity are pretreated with
oral antioxidants [33]. A summative review by Kumalic
and Pinter substantiated the beneficial effects of antioxi-
dant therapy, albiet most of these results are based upon
ejaculated samples [34]. In our practice we routinely
offer men with asthenospermia supplementation with
coenzyme Q10. It remains unclear if the outcomes
would have differed if the men in this case series were
offered a formal course of antioxidant therapy. Further
studies are needed to expand upon the preliminary re-
sults of Greco et al., in which testicular sperm may be
further optimized through oral antioxidants [33].
In regards to Case 3, little is known about the patho-
physiology of poor IVF-ICSI outcomes in Kartagener’s
Syndrome. Given the rarity of the disease, most of the
primary literature is based upon case reports [35]. It is
assumed that Kartagener’s Syndrome results in longer
transit times through the epididymis, which may result
in greater oxidative damage, cell senescence, and loss of
DNA integrity [36, 37]. An analysis by Cayan et al. dem-
onstrated substantial improvement of sperm viability
with testicular sperm in one patient, presumably bypass-
ing the damage that may develop within the epididymis
[38]. Additionally, Westlander and colleagues concluded
that more reliable fertilization rates can be achieved with
testicular sperm [37]. Future studies are needed to define
a link between this rare syndrome and elevated oxidative
stress and/or increased DNA fragmentation.
The optimal source of sperm for IVF-ICSI remains
controversial [11, 39]. Two recent series have compared
the results of IVF-ICSI between ejaculated and testicular
sperm. Lu et al. found a slight advantage of ejaculated
sperm in terms of fertilization rates and embryo quality
within one center’s large experience [4]. Similarly, Gnoth
and colleagues analyzed 337 IVF-ICSI cycles and found
no difference in clinical outcomes between ejaculated
and testicular sperm for men with cryptozoospermia [6].
Both studies were limited by a retrospective design with
significant potential for selection bias. In each case a tes-
ticular sperm extraction was used only when sperm
could not be reliably found within the ejaculate. Neither
study compared IVF-ICSI outcomes between ejaculated
and matched testicular derived sperm from the same in-
dividual. Additionally, these studies did not stratify for
the cohort of men who have had repeated IVF-ICSI fail-
ure, a group that may benefit from testis-derived sperm
[10, 11, 40, 41]. Our small case series documents a pos-
sible benefit for this population. It should be noted,
however, that our study is also limited by a retrospective
design. Additionally, the criteria used to select for
PercBx was not standardized at our institution, and so
one must consider a component of selection bias. Des-
pite these limitations in study design, our data do sug-
gest an indication for retrieving testicular sperm despite
sperm availability within the ejaculate. Further studies
are needed to confirm our observations.
Conclusions
It remains to be elucidated if patients with recurrent
IVF-ICSI failure have progressive deterioration of sperm
quality, and therefore worse pregnancy outcomes, due to
sperm passage through the male reproductive tract [26].
Larger studies are ultimately needed to substantiate
these pilot investigations and preliminary observations.
Until these data are obtained, for couples who undergo
repeated unsuccessful cycles of IVF-ICSI with ejaculated
sperm, a trial of freshly procured testicular sperm may
offer an improved chance to achieve parenthood.
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